SOUTH SAN FRANCISCO, Calif., June 15, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of ...
Proceedings of the Royal Society of London. Series A, Mathematical and Physical Sciences, Vol. 233, No. 1192 (Dec. 6, 1955), pp. 126-146 (21 pages) ...
LAUSANNE, Switzerland & SUWON-SI GYEONGGI-DO, South Korea--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s ...
Kyung-Ah Kim, President & CEO of Samsung Bioepis (left) and Zhaoyuan ‘Tony’ Chen, Founder and CEO of Phrontline Biopharma (right) have signed a global strategic partnership agreement to advance ...
BioWorld - Saturday, September 20, 2025 Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » First-in-class drug-Fc conjugate shows ...
SUZHOU, China, April 18, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an ...
NaPi2b is a sodium-dependent phosphate transporter that is mainly responsible for phosphate homeostasis in humans. Overexpression of NaPi2b has been associated with several types of cancers such as ...
PALO ALTO, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...
An announcement from CanSino Biologics, Inc. Class H ( ($HK:6185) ) is now available. CanSino Biologics Inc. has received approval from China’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback